Ingenia Therapeutics Inc. (KOSDAQ: A950260)
Health Care · Biotechnology · US
₩20,350.00
+1.24% today · +13.1% 1Y
Public summary
A free snapshot of Ingenia Therapeutics Inc., with figures as of Nov 15, 2026. The full analysis is in the app.Open in the app Ingenia Therapeutics Inc. (KOSDAQ: A950260) operates in the Biotechnology industry within the Health Care sector. The company is valued at $752.71M.
Over the last twelve months the share price has gained 13.1%, trading between 9.90K and 29.95K.
Tweenvest scores Ingenia Therapeutics Inc. across four factors: quality 56/100, value 67/100. Its strongest factor is value.
A950260 price history
Key figures
- Market cap
- $752.71M
- Revenue (TTM)
- $4.79M
- P/E
- -97.12
- EPS
- -163.00
- Dividend yield
- —
- Beta (5Y)
- —
- 52-week high
- ₩29,950.00
- 52-week low
- ₩9,900.00
- Avg volume (3M)
- —
- Shares outstanding
- 49.44M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Monte Rosa Therapeutics, Inc.NasdaqGS: GLUE | $775.03M | $9.07 | 0.00% |
| Kolon TissueGene, Inc.KOSDAQ: A950160 | $772.30M | ₩12,150.00 | -3.19% |
| Obsidian Therapeutics, Inc.NasdaqCM: OBX | $754.25M | $12.21 | +1.16% |
| Inventiva S.A.ENXTPA: IVA | $753.92M | €2.91 | +0.69% |
| Nanjing Leads Biolabs Co., Ltd.SEHK: 9887 | $748.03M | HK$30.08 | -1.96% |
| Beijing SL Pharmaceutical Co., Ltd.SZSE: 002038 | $745.83M | CN¥4.84 | -2.22% |
| Aura Biosciences, Inc.NasdaqGM: AURA | $743.09M | $7.14 | -0.14% |
| Sagimet Biosciences Inc.NasdaqGM: SGMT | $721.53M | $10.11 | +2.54% |